Search research articles
Contact Us
Filters
Showing results (471-480 of 483) with videos related to
Page
of 49
Sort By:
Nature
|
May 17, 2002
Targeted pharmacological depletion of serum amyloid P component for treatment of human amyloidosis
M B Pepys, J Herbert, W L Hutchinson, et al.
Journal of Medicinal Chemistry
|
November 21, 2014
Lead optimization of a pyrazole sulfonamide series of Trypanosoma brucei N-myristoyltransferase inhibitors: identification and evaluation of CNS penetrant compounds as potential treatments for stage 2 human African trypanosomiasis
Stephen Brand, Neil R Norcross, Stephen Thompson, et al.
Journal of Medicinal Chemistry
|
May 25, 2010
Selective GlyT1 inhibitors: discovery of [4-(3-fluoro-5-trifluoromethylpyridin-2-yl)piperazin-1-yl][5-methanesulfonyl-2-((S)-2,2,2-trifluoro-1-methylethoxy)phenyl]methanone (RG1678), a promising novel medicine to treat schizophrenia
Emmanuel Pinard, Alexander Alanine, Daniela Alberati, et al.
Journal of Medicinal Chemistry
|
November 10, 2023
Identification and Optimization of Novel Inhibitors of the Polyketide Synthase 13 Thioesterase Domain with Antitubercular Activity
Simon R Green, Caroline Wilson, Thomas C Eadsforth, et al.
Journal of Medicinal Chemistry
|
September 16, 2016
Discovery of a Quinoline-4-carboxamide Derivative with a Novel Mechanism of Action, Multistage Antimalarial Activity, and Potent in Vivo Efficacy
Beatriz Baragaña, Neil R Norcross, Caroline Wilson, et al.
Chemmedchem
|
June 13, 2019
Substituted Aminoacetamides as Novel Leads for Malaria Treatment
Neil R Norcross, Caroline Wilson, Beatriz Baragaña, et al.
Journal of Medicinal Chemistry
|
June 18, 2016
Trisubstituted Pyrimidines as Efficacious and Fast-Acting Antimalarials
Neil R Norcross, Beatriz Baragaña, Caroline Wilson, et al.
Science Translational Medicine
|
October 23, 2024
<i>Cryptosporidium</i> lysyl-tRNA synthetase inhibitors define the interplay between solubility and permeability required to achieve efficacy
Nicola Caldwell, Caroline Peet, Peter Miller, et al.
The AAPS Journal
|
February 12, 2026
Proceedings of the 2024 FDA-CRCG Workshop: Scientific and Regulatory Considerations for Assessment of Immunogenicity Risk for Generic Peptide and Oligonucleotide Drug Products
Jennifer K Lee, Ha-Na Lee, Sudhir Agrawal, et al.
Journal of Dermatological Science
|
March 21, 2020
SJS/TEN 2019: From science to translation
Wan-Chun Chang, Riichiro Abe, Paul Anderson, et al.
Page
of 49
Search research articles
Search
Showing results (471-480 of 483) with videos related to
Sort By:
Page
of 49
Nature
|
May 17, 2002
Targeted pharmacological depletion of serum amyloid P component for treatment of human amyloidosis
M B Pepys, J Herbert, W L Hutchinson, et al.
Journal of Medicinal Chemistry
|
November 21, 2014
Lead optimization of a pyrazole sulfonamide series of Trypanosoma brucei N-myristoyltransferase inhibitors: identification and evaluation of CNS penetrant compounds as potential treatments for stage 2 human African trypanosomiasis
Stephen Brand, Neil R Norcross, Stephen Thompson, et al.
Journal of Medicinal Chemistry
|
May 25, 2010
Selective GlyT1 inhibitors: discovery of [4-(3-fluoro-5-trifluoromethylpyridin-2-yl)piperazin-1-yl][5-methanesulfonyl-2-((S)-2,2,2-trifluoro-1-methylethoxy)phenyl]methanone (RG1678), a promising novel medicine to treat schizophrenia
Emmanuel Pinard, Alexander Alanine, Daniela Alberati, et al.
Journal of Medicinal Chemistry
|
November 10, 2023
Identification and Optimization of Novel Inhibitors of the Polyketide Synthase 13 Thioesterase Domain with Antitubercular Activity
Simon R Green, Caroline Wilson, Thomas C Eadsforth, et al.
Journal of Medicinal Chemistry
|
September 16, 2016
Discovery of a Quinoline-4-carboxamide Derivative with a Novel Mechanism of Action, Multistage Antimalarial Activity, and Potent in Vivo Efficacy
Beatriz Baragaña, Neil R Norcross, Caroline Wilson, et al.
Chemmedchem
|
June 13, 2019
Substituted Aminoacetamides as Novel Leads for Malaria Treatment
Neil R Norcross, Caroline Wilson, Beatriz Baragaña, et al.
Journal of Medicinal Chemistry
|
June 18, 2016
Trisubstituted Pyrimidines as Efficacious and Fast-Acting Antimalarials
Neil R Norcross, Beatriz Baragaña, Caroline Wilson, et al.
Science Translational Medicine
|
October 23, 2024
<i>Cryptosporidium</i> lysyl-tRNA synthetase inhibitors define the interplay between solubility and permeability required to achieve efficacy
Nicola Caldwell, Caroline Peet, Peter Miller, et al.
The AAPS Journal
|
February 12, 2026
Proceedings of the 2024 FDA-CRCG Workshop: Scientific and Regulatory Considerations for Assessment of Immunogenicity Risk for Generic Peptide and Oligonucleotide Drug Products
Jennifer K Lee, Ha-Na Lee, Sudhir Agrawal, et al.
Journal of Dermatological Science
|
March 21, 2020
SJS/TEN 2019: From science to translation
Wan-Chun Chang, Riichiro Abe, Paul Anderson, et al.
Page
of 49